Alpha 2.0
Login Register
» Articles » PMID: 28698204

Hematologic Relapse in AL Amyloidosis After High-dose Melphalan and Stem Cell Transplantation

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2017 Jul 13
PMID 28698204
Citations 12
Authors
Sabrina Browning
Karen Quillen
J Mark Sloan
Gheorghe Doros
Shayna Sarosiek
Vaishali Sanchorawala
Affiliations
Soon will be listed here.
Citing Articles

Risk factors, treatments and outcomes of patients with light chain amyloidosis who relapse after autologous stem cell transplantation.

Zhang Y, Guo J, Chen W, Zhao L, Huang X Bone Marrow Transplant. 2023; 59(3):350-358.

PMID: 38148411 DOI: 10.1038/s41409-023-02185-z.

Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics.

Fraser C, Spetz J, Qin X, Presser A, Choiniere J, Li C Nat Commun. 2022; 13(1):5789.

PMID: 36184661 PMC: 9527241. DOI: 10.1038/s41467-022-33461-z.

Treatment and outcomes of patients with light chain amyloidosis who received a second line of therapy post autologous stem cell transplantation.

Saleh A, Ebraheem M, Sidiqi M, Dispenzieri A, Muchtar E, Buadi F Blood Cancer J. 2022; 12(4):59.

PMID: 35410992 PMC: 9001695. DOI: 10.1038/s41408-022-00655-z.

An eye-catching atypical illustration of the evaluation and management of AL amyloidosis secondary to myeloma.

Khan S, Premji S, Huang Q, Verstovsek G, Bushan S, Yellapragada S Clin Case Rep. 2021; 9(12):e05176.

PMID: 34938552 PMC: 8659555. DOI: 10.1002/ccr3.5176.

Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study.

Staron A, Zheng L, Doros G, Connors L, Mendelson L, Joshi T Blood Cancer J. 2021; 11(8):139.

PMID: 34349108 PMC: 8338947. DOI: 10.1038/s41408-021-00529-w.